Cargando…
Editorial: Anakoinosis: An Innovative Anticancer Therapy Targeting the Aberrant Cancer Tissue Homeostasis
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528999/ https://www.ncbi.nlm.nih.gov/pubmed/34690792 http://dx.doi.org/10.3389/fphar.2021.779021 |
| _version_ | 1784586370649423872 |
|---|---|
| author | Heudobler, Daniel Reichle, Albrecht Ghibelli, Lina |
| author_facet | Heudobler, Daniel Reichle, Albrecht Ghibelli, Lina |
| author_sort | Heudobler, Daniel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8528999 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85289992021-10-22 Editorial: Anakoinosis: An Innovative Anticancer Therapy Targeting the Aberrant Cancer Tissue Homeostasis Heudobler, Daniel Reichle, Albrecht Ghibelli, Lina Front Pharmacol Pharmacology Frontiers Media S.A. 2021-10-07 /pmc/articles/PMC8528999/ /pubmed/34690792 http://dx.doi.org/10.3389/fphar.2021.779021 Text en Copyright © 2021 Heudobler, Reichle and Ghibelli. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Heudobler, Daniel Reichle, Albrecht Ghibelli, Lina Editorial: Anakoinosis: An Innovative Anticancer Therapy Targeting the Aberrant Cancer Tissue Homeostasis |
| title | Editorial: Anakoinosis: An Innovative Anticancer Therapy Targeting the Aberrant Cancer Tissue Homeostasis |
| title_full | Editorial: Anakoinosis: An Innovative Anticancer Therapy Targeting the Aberrant Cancer Tissue Homeostasis |
| title_fullStr | Editorial: Anakoinosis: An Innovative Anticancer Therapy Targeting the Aberrant Cancer Tissue Homeostasis |
| title_full_unstemmed | Editorial: Anakoinosis: An Innovative Anticancer Therapy Targeting the Aberrant Cancer Tissue Homeostasis |
| title_short | Editorial: Anakoinosis: An Innovative Anticancer Therapy Targeting the Aberrant Cancer Tissue Homeostasis |
| title_sort | editorial: anakoinosis: an innovative anticancer therapy targeting the aberrant cancer tissue homeostasis |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528999/ https://www.ncbi.nlm.nih.gov/pubmed/34690792 http://dx.doi.org/10.3389/fphar.2021.779021 |
| work_keys_str_mv | AT heudoblerdaniel editorialanakoinosisaninnovativeanticancertherapytargetingtheaberrantcancertissuehomeostasis AT reichlealbrecht editorialanakoinosisaninnovativeanticancertherapytargetingtheaberrantcancertissuehomeostasis AT ghibellilina editorialanakoinosisaninnovativeanticancertherapytargetingtheaberrantcancertissuehomeostasis |